Safety of 5-hydroxy-l-tryptophan
- 11 March 2004
- journal article
- case report
- Published by Elsevier in Toxicology Letters
- Vol. 150 (1) , 111-122
- https://doi.org/10.1016/j.toxlet.2003.12.070
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Accumulation of 1-methyl-tetrahydro-Β-carboline-3-carboxylic acid in blood and organs of rat. A possible causative substance of eosinophilia-myalgia syndrome associated with ingestion ofl-tryptophanArchives of Toxicology, 1993
- Development of pseudobullous morphea and scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopaJournal of the American Academy of Dermatology, 1991
- Effect of synthesized constituents in the L-tryptophan product on the differentiation of eosinophils and the induction of IL-6: A possible cause of eosinophilia-myalgia syndromeBiochemical and Biophysical Research Communications, 1991
- Scleroderma, Fasciitis, and Eosinophilia Associated with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Association of the Eosinophilia–Myalgia Syndrome with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Electrochemical Oxidation of 5-Hydroxytryptophan in Acid SolutionJournal of Pharmaceutical Sciences, 1987
- Clinical Epidemiology of Toxic-Oil SyndromeNew England Journal of Medicine, 1983
- L-5-Hydroxytryptophan in Depression: the First Substitution Therapy in Psychiatry?Neuropsychobiology, 1980
- L-5-HTP Treatment and Serum 5-HT Level after L-5-HTP Loading on Depressed PatientsNeuropsychobiology, 1979
- 5-HYDROXYTRYPTOPHAN FOR DEPRESSIONThe Lancet, 1967